Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Rau

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Innere Medizin (Heidelberg, Germany)|May 23, 2023
[Sarcopenia in chronic liver diseases]Monika Rau
Innere Medizin (Heidelberg, Germany)|September 14, 2023
[Does alcohol minimum unit pricing lead to a reduction in deaths and hospitalizations?]Monika Rau, Sirka Nitschmann
Expert Review of Clinical Pharmacology|February 4, 2021
An update on drug development for the treatment of nonalcoholic fatty liver disease - from ongoing clinical trials to future therapyMonika Rau, Andreas Geier
Deutsches Arzteblatt International|April 6, 2025
Delayed Gastric Emptying Under Treatment with GLP-1 AgonistsMonika Rau, Alexander Meining
Journal of Hepatology|May 28, 2013
Reply to: "estimating ribavirin plasma exposure: genetics or therapeutic drug monitoring?"Monika Rau, Andreas Geier
Expert Review of Clinical Pharmacology|March 10, 2017
Emerging therapies for NASH - the future is nowAndreas Geier, Monika Rau
Zeitschrift Fur Gastroenterologie|July 16, 2025
[The importance of nutritional medicine in patient care, medical training, and research - from a management perspective]Katharina Hupa-Breier, Monika Rau
Deutsches Arzteblatt International|March 24, 2015
In replyJohannes Weiß, Monika Rau, Andreas Geier
Deutsches Arzteblatt International|July 15, 2014
Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatmentJohannes Weiß, Monika Rau, Andreas Geier
Deutsche Medizinische Wochenschrift (1946)|July 17, 2015
[Non-alcoholic fatty liver disease (NAFLD)]Monika Rau, Johannes Weiss, Andreas Geier
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Innere Medizin (Heidelberg, Germany)|May 23, 2023
[Sarcopenia in chronic liver diseases]Monika Rau
Innere Medizin (Heidelberg, Germany)|September 14, 2023
[Does alcohol minimum unit pricing lead to a reduction in deaths and hospitalizations?]Monika Rau, Sirka Nitschmann
Expert Review of Clinical Pharmacology|February 4, 2021
An update on drug development for the treatment of nonalcoholic fatty liver disease - from ongoing clinical trials to future therapyMonika Rau, Andreas Geier
Deutsches Arzteblatt International|April 6, 2025
Delayed Gastric Emptying Under Treatment with GLP-1 AgonistsMonika Rau, Alexander Meining
Journal of Hepatology|May 28, 2013
Reply to: "estimating ribavirin plasma exposure: genetics or therapeutic drug monitoring?"Monika Rau, Andreas Geier
Expert Review of Clinical Pharmacology|March 10, 2017
Emerging therapies for NASH - the future is nowAndreas Geier, Monika Rau
Zeitschrift Fur Gastroenterologie|July 16, 2025
[The importance of nutritional medicine in patient care, medical training, and research - from a management perspective]Katharina Hupa-Breier, Monika Rau
Deutsches Arzteblatt International|March 24, 2015
In replyJohannes Weiß, Monika Rau, Andreas Geier
Deutsches Arzteblatt International|July 15, 2014
Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatmentJohannes Weiß, Monika Rau, Andreas Geier
Deutsche Medizinische Wochenschrift (1946)|July 17, 2015
[Non-alcoholic fatty liver disease (NAFLD)]Monika Rau, Johannes Weiss, Andreas Geier
Pageof 6